Phase 2: patient satisfaction score and preference# at the end of the acute¶ treatment phase
| Patient satisfaction score | |
| Subjects n | 124 |
| Score | |
| 0–4 | 0 (0) |
| 5–7 | 9 (7.3) |
| 8 | 19 (15.3) |
| 9 | 15 (12.1) |
| 10 | 81 (65.3) |
| Mean±sd | 9.28±1.2 |
| Mean (95% CI) | 9.28 (9.07–9.49) |
| Patient preference | |
| Subjects n | 149 |
| Management | |
| In-patient | 5 (3.4) |
| Outpatient | 144 (96.6) |
Data are presented as n (%), unless otherwise stated. CI: confidence interval. #: 33 patients did not complete the patient satisfaction score and eight did not indicate treatment preference. ¶: low molecular weight heparin.